Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis

WHO. Control of the leishmaniases. Geneva: World Health Organization; 2010. Technical Report Series No. 949. Ganguly, 2010, Post-kala-azar dermal leishmaniasis- an overview, Int J Dermatol, 49, 921, 10.1111/j.1365-4632.2010.04558.x Mondal, 2009, Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy, PLoS Negl Trop Dis, 3, 355, 10.1371/journal.pntd.0000355 Zilstra, 2003, Post-kala-azar dermal leishmaniasis, Lancet Infect Dis, 3, 87, 10.1016/S1473-3099(03)00517-6 Rathi, 2005, Post-kala-azar dermal leishmaniasis: a histopathological study, Indian J Dermatol Venereol Leprol, 71, 250, 10.4103/0378-6323.16616 Ghosh, 1995, Immunoglobulin G subclass-specific antileishmanial antibody responses in Indian kala-azar and post-kala-azar dermal leishmaniasis, Clin Diagn Lab Immunol, 2, 291, 10.1128/CDLI.2.3.291-296.1995 Ansari, 2008, Elevated levels of IgG3 and IgG4 subclass in paediatric cases of kala azar, Parasite Immunol, 30, 403, 10.1111/j.1365-3024.2008.01036.x Musa, 2005, Efficacy of liposomal amphotericn B (AmBisome) in the treatment of persistent post kala-azar dermal leishmaniasis (PKDL), Ann Trop Med Parasitol, 99, 563, 10.1179/136485905X514127 Ghosh S, Banerjee P, Sarkar A, Ganguly S, Datta S, Chatterjee. Co-infection of Leptomonas seymouri with Leishmania donovani in Indian Leishmaniasis. J Clin Microbiol May 2012, http:/dx.doi.org/10.1128/JCM.00966-1. Chatterjee, 1998, Distribution of IgG subclasses in antimonial unresponsive Indian kala-azar patients, Clin Exp Immunol, 114, 408, 10.1046/j.1365-2249.1998.00752.x Lowry, 1995, Protein measurement with the Folin phenol reagent, J Biol Chem, 193, 265, 10.1016/S0021-9258(19)52451-6 Snider, 2009, Sex hormones and modulation of immunity against leishmaniasis, Neuroimmunomodulation, 16, 106, 10.1159/000180265 Saha, 2006, Immune responses in kala-azar, Indian J Med Res, 123, 245 Castellano, 2009, Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production, Hum Immunol, 70, 383, 10.1016/j.humimm.2009.01.007 el Amin, 1986, Characterization of the humoral immune response in Sudanese leishmaniasis: specific antibody detected by class- and subclass-specific reagents, Clin Exp Immunol, 64, 14 Haldar, 1981, Serological profiles in Indian post kala-azar dermal leishmaniasis, Trans R Soc Trop Med Hyg, 75, 514, 10.1016/0035-9203(81)90188-7 Miles, 2005, A role for IgG immune complexes during infection with the intracellular pathogen Leishmania, J Exp Med, 201, 747, 10.1084/jem.20041470 Kane, 2001, The role of IL-10 in promoting disease progression in leishmaniasis, J Immunol, 166, 1141, 10.4049/jimmunol.166.2.1141 Elassad, 1994, The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients, Clin Exp Immunol, 95, 294, 10.1111/j.1365-2249.1994.tb06526.x Sharma, 2009, Immunobiology of leishmaniasis, Indian J Exp Biol, 47, 412 Salotra, 2003, Parasite detection in patients with post kala-azar dermal leishmaniasis in India: a comparison between molecular and immunological methods, J Clin Pathol, 56, 840, 10.1136/jcp.56.11.840 Anam, 1999, Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy, Infect Immun, 67, 6663, 10.1128/IAI.67.12.6663-6669.1999 Atta, 1998, Anti-leishmanial IgE antibodies: a marker of active disease in visceral leishmaniasis, Am J Trop Med Hyg, 59, 426, 10.4269/ajtmh.1998.59.426 Cabrera, 2003, Variations in the serum levels of soluble CD23, nitric oxide and IgE across the spectrum of American cutaneous leishmaniasis, Acta Trop, 88, 145, 10.1016/S0001-706X(03)00198-0 Sousa-Atta, 2002, Immunoglobulin E antileishmanial antibody response in cutaneous leishmaniasis, Clin Diagn Lab Immunol, 9, 101 Saha, 2005, Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis, J Clin Microbiol, 43, 1269, 10.1128/JCM.43.3.1269-1277.2005 Chappuis, 2007, Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?, Nat Rev Microbiol, 5, 873, 10.1038/nrmicro1748 Ganguly, 2008, Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis, J Infect Dis, 197, 1762, 10.1086/588387 Schultz, 1994, Control of isotype switching by T cells and cytokines, Curr Opin Immunol, 3, 350, 10.1016/0952-7915(91)90037-2 Briere, 1994, Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3, J Exp Med, 179, 757, 10.1084/jem.179.2.757 Gascan, 1994, Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones, J Exp Med, 173, 747, 10.1084/jem.173.3.747 Kawano, 1994, Regulation of human IgG subclass production by cytokines IFN-γ and IL-6 acts antagonistically in the induction of human IgG1 but additively in the induction of IgG2, J Immunol, 153, 4948, 10.4049/jimmunol.153.11.4948 Finkelman, 1990, Lymphokine control of in vivo immunoglobulin isotype selection, Annu Rev Immunol, 8, 303, 10.1146/annurev.iy.08.040190.001511 Kenney, 1998, Splenic cytokine responses in Indian kala-azar before and after treatment, J Infect Dis, 177, 815, 10.1086/517817 Redhu, 2006, Use of immunoglobulin g avidity to determine the course of disease in visceral and post-kala-azar dermal leishmaniasis patients, Clin Vaccine Immunol, 13, 969, 10.1128/CVI.00149-06